WZWeihua Zhang

Weihua Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Weihua Zhang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Yuehua Liu

    Department of Orthodontics, Shanghai Stomatological Hospital & School of Stomatology, Fudan University

    3 shared publications
  • Jiao Li

    Shanghai Key laboratory of Craniomaxillofacial Development and Diseases, Shanghai Stomatological Hospital and School of Stomatology, Fudan University, Shanghai, China

    2 shared publications
  • Jie Pan

    Department of Orthodontics Shanghai Stomatological Hospital School of Stomatology Fudan University Shanghai China

    2 shared publications
  • Liming Yu

    Shanghai Key Laboratory of Craniomaxillofacial Development and Diseases , Shanghai Stomatological Hospital , Shanghai , China

    2 shared publications
  • Yun Lu

    Department of Orthodontics, Shanghai Stomatological Hospital & School of Stomatolog, Fudan University, Shanghai, China

    2 shared publications
  • Bing-Jing Sun

    Shanghai Key laboratory of Craniomaxillofacial Development and Diseases, Shanghai Stomatological Hospital and School of Stomatology, Fudan University, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Efficacy of anterior intrusion-based vertical control versus conventional sagittal retraction in adolescents with hyperdivergent mandibular retrognathia: study protocol for a randomised controlled trial

    by Shuangshuang Shi, Wei Zhang, Weihua Zhang, Meixiu Lin, Xu Chenyi, Yun Lu, Yuehua Liu

    Introduction: Hyperdivergent skeletal class II malocclusion in adolescents is characterised by mandibular retrognathia with excessive vertical growth and clockwise mandibular rotation, which can worsen facial profile and airway-related morphology. Although mandibular advancement approaches are commonly used, they may increase the vertical dimension and are suboptimal for patients with long-face patterns. This randomised controlled trial aims to evaluate a micro-implant-assisted protrusion correction technique designed to flatten the occlusal plane and promote counterclockwise mandibular rotation, thereby improving facial profile and pharyngeal space. Methods and analysis: This trial is registered at the Chinese Clinical Trial Registry (ChiCTR; ChiCTR2100054105). This is a two-arm, multicentre, randomised, parallel-controlled trial. Ninety adolescents will be recruited from Shanghai Stomatological Hospital, Zhongshan Hospital (Fudan University), and Xinhua Hospital (Shanghai Jiao Tong University School of Medicine), and will be randomly allocated (1:1) to the test or control group. The control group will receive conventional anterior teeth retraction, whereas the test group will receive a micro-implant-assisted vertical control protocol with occlusal plane flattening. The primary outcome is the change in the A point–nasion–B point angle. Secondary outcomes include changes in the occlusal plane, incisor and molar heights, and facial height. Measurements will be assessed at baseline, at the end of treatment and at 12 months after treatment completion. Ethics and dissemination: This study was approved by the Ethics Committee of the Shanghai Stomatological Hospital (approval no. (2022)006). The results of this study will be made available in peer-reviewed journals. Trial registration number: ChiCTR2100054105.

  • Open Access

    β‐Nicotinamide Mononucleotide Inhibits Cellular Senescence in Mouse C2C12 Skeletal Muscle Cells

    by Jing Mi, Chenxin Wang, Hongfei Gu, Mengxuan Wang, Weihua Zhang, Qiangqiang Zhou, Yuejiao Zhang, Jie Pan, Liming Yu

    β‐Nicotinamide mononucleotide (NMN), as the precursor of nicotinamide adenine dinucleotide (NAD + ), has remarkable therapeutic potential in aging‐associated diseases. Skeletal muscle exhibits not only reduced mass but also impaired strength and function during aging. However, the protective effects of NMN against skeletal muscle cell senescence remain to be fully elucidated. In this study, we used D‐galactose (D‐gal) to establish a senescence model in C2C12 cells. Our results demonstrate that aging C2C12 cells displayed a significant impairment in differentiation capacity, an effect that was ameliorated by NMN treatment, as indicated by an increase in myotube formation and elevated myosin heavy chain (MHC) expression. NMN significantly decreased reactive oxygen species (ROS) levels in both aged C2C12 myoblasts and myotubes. NMN treatment downregulated the mRNA expression of aging‐associated markers, including tumor protein p53 ( Trp53 ), poly (ADP-ribose) polymerases ( PARPs ), and interleukin-1α ( IL-1α ) in aged C2C12 myotubes. Immunofluorescence staining revealed that the expressions of p53 and interleukin‐1β (IL‐1β) were significantly upregulated in aged C2C12 myotubes, while NMN treatment significantly attenuated this elevation. Collectively, the present study demonstrates that NMN treatment attenuates D‐gal–induced ROS accumulation, enhances myotube formation, and downregulates several senescence‐associated molecules. Therefore, our findings suggest that NMN represents a promising therapeutic agent for mitigating skeletal muscle cell aging.

  • Open Access

    Geometrically-engineered human motor assembloids-on-a-chip for neuromuscular interaction readout and hypoxia-driven disease modeling

    by Weihua Zhang, Liming Yu, Jie Pan, Jiajia Deng, Xianqin Tong, Bingjiao Zhao, Wen Liu, Liangyan Sun, Menghan Zhang, Xinxin Han, et al.

    Precision medicine leverages stem cell-derived models to dissect complex interactions underlying disease-driven neuromuscular damage. However, such reductionist models form stochastic structures without external guidance, while available engineering solutions remain intricate. Here, simplified surface modification engineering is used to render spatially patterned human motor assembloids-on-a-chip by geometric confinement. The anisotropic architecture of skeletal muscle organoids (hSkM) can be conferred solely by localized mechanobiological cues within this predefined device without aligned scaffolds or adjuncts. The hSkM-orchestrated coupling of motor neuron spheroids (hMNS) promotes synergistic neuromuscular development. Furthermore, integration of optogenetic and microelectrode array mapping enables visualization of functional patterning in assembloids. Applied to oxygen deprivation model, hSkM exhibits structural anomalies, fatigable muscle remodeling and dysfunction, recapitulating muscle pathologies in intermittent hypoxia (IH)-associated respiratory disorders. Electrical activity mapping reveals the heterogeneity in neuromuscular responses to IH, indicating the neuroregulatory etiology of muscle dysfunction. Finally, we identify mitochondrial bioenergetic imbalance as a key IH target, proposing evaluation of NAD+ salvage pathway-targeting agents. Our findings provide an accessible platform with translational potential for neuromuscular physiopathology research.


  • Open Access

    Noggin Combined With Human Dental Pulp Stem Cells to Promote Skeletal Muscle Regeneration

    by Meng-Han Zhang, Li-Ming Yu, Wei-Hua Zhang, Jia-Jia Deng, Bing-Jing Sun, Mei-Hua Chen, Wei Huang, Jiao Li, Hua He, Xin-Xin Han, et al.

    A proper source of stem cells is key to muscle injury repair. Dental pulp stem cells (DPSCs) are an ideal source for the treatment of muscle injuries due to their high proliferative and differentiation capacities. However, the current myogenic induction efficiency of human DPSCs hinders their use in muscle regeneration due to the unknown induction mechanism. In this study, we treated human DPSCs with Noggin, a secreted antagonist of bone morphogenetic protein (BMP), and discovered that Noggin can effectively promote myotube formation. We also found that Noggin can accelerate the skeletal myogenic differentiation (MyoD) of DPSCs and promote the generation of Pax7+ satellite‐like cells. Noggin increased the expression of myogenic markers and the transcriptional and translational abundance of satellite cell (SC) markers in DPSCs. Moreover, BMP4 inhibited Pax7 expression and activated p‐Smad1/5/9, while Noggin eliminated BMP4‐induced p‐Smad1/5/9 in DPSCs. This finding suggests that Noggin antagonizes BMP by downregulating p‐Smad and facilitates the MyoD of DPSCs. Then, we implanted Noggin‐pretreated DPSCs combined with Matrigel into the mouse tibialis anterior muscle with volumetric muscle loss (VML) and observed a 73% reduction in the size of the defect and a 69% decrease in scar tissue. Noggin‐treated DPSCs can benefit the Pax7+ SC pool and promote muscle regeneration. This work reveals that Noggin can enhance the production of satellite‐like cells from the MyoD of DPSCs by regulating BMP/Smad signaling, and these satellite‐like cell bioconstructs might possess a relatively fast capacity for muscle regeneration.